NASDAQ · TEBRX
Teberg Fund
$35.79-$0.24 (-0.67%)
Teberg Fund’s quoted price sits in the upper half of its reported 52-week range, 6.5% below the high.
Loading market information…
NASDAQ · BUFOX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 12:10 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Buffalo Early Stage Growth Fund’s quoted price sits in the upper half of its reported 52-week range, 9.62% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Buffalo Early Stage Growth Fund’s forward annual dividend is $0.17 per share, paid annual. The forward yield is 0.95% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The Buffalo Early Stage Growth Fund primarily allocates at least 80% of its total capital, including any funds acquired through borrowing for investment, to a diverse range of equity instruments. These investments comprise common stock, preferred shares, convertible bonds, warrants, and rights, all sourced from companies that the advisor designates as "early stage growth" at the point of acquisition. While mainly concentrated on domestic holdings, the fund also maintains the flexibility to channel up to 20% of its net assets into international opportunities, specifically through sponsored or unsponsored American Depositary Receipts (ADRs) and equity securities of foreign corporations that are publicly traded on U.S. stock exchanges.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:31 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$35.79-$0.24 (-0.67%)
Teberg Fund’s quoted price sits in the upper half of its reported 52-week range, 6.5% below the high.
$30.48+$0.40 (+1.33%)
Keeley Small Cap Fund AAA’s quoted price sits in the upper half of its reported 52-week range, 8.72% below the high.
$27.03-$0.10 (-0.37%)
Virtus NFJ International Value Fund’s quoted price sits in the upper half of its reported 52-week range, 8.15% below the high.
$39.91-$0.25 (-0.62%)
Sit Balanced’s quoted price sits in the upper half of its reported 52-week range, 3.95% below the high.
$33.57+$0.13 (+0.39%)
Guggenheim StylePlus - Mid Growth Fund’s quoted price sits in the lower half of its reported 52-week range, 17.03% below the high.
$17.51-$0.06 (-0.34%)
Baron FinTech Fund’s quoted price sits in the upper half of its reported 52-week range, 6.26% below the high.
$10.16-$0.11 (-1.02%)
The European Equity Fund, Inc.’s quoted price sits in the lower half of its reported 52-week range, 11.15% below the high.
$12.06+$0.01 (+0.08%)
T. Rowe Price Target Retirement 2010 Fund’s quoted price sits in the upper half of its reported 52-week range, 1.23% below the high.
